Immunetics, Inc. Release: FDA Approves First Blood Test For Anthrax; Boston Based Company Test Shown To Be Accurate For Anthrax Diagnosis
10/19/2005 5:11:42 PM
Immunetics, Inc. today announced the approval by the Food and Drug Administration of its test for anthrax infection. The approval, received late Friday, June 4, 2004, represents a significant step forward in the public health community's ability to diagnose anthrax. The Immunetics test is the first for anthrax approved by the FDA for direct use on patient blood specimens. Unlike many of the procedures previously available only in a small number of government laboratories, the new test can be used by any clinical or public health laboratory without the need for specialized equipment or training. Test results will be used together with other clinical evidence by physicians and healthcare workers to diagnose anthrax in suspected cases. The test was shown to detect 100% of the anthrax patients tested in clinical trials, with less than a 1% chance of false positive results.
comments powered by